Shopping Cart 0
Cart Subtotal
AED 0

National Cancer Center Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

National Cancer Center Hospital (NCC) is a healthcare service provider that offers cancer care services. The hospital provides cancer diagnosis and treatment services. It provides services such as examination, treatment, patient care services and co-medical support. NCC provides diagnosis and treatments by utilizing advanced screening and examination protocols with high-tech systems and equipment. It offers services in the areas of thoracic surgery, breast surgery, palliative care, chemotherapy, neurosurgery, ophthalmic oncology, head and neck oncology, endoscopic treatment and radiotherapy, among others. The hospital also provides consultation and examinations services by advanced computer system in the clinics. NCC is headquartered in Tokyo, Japan.

National Cancer Center Hospital-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Cancer Center Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

KAN Research Institute Enters into Development Agreement with Six Research Organizations 12

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 14

Oncolys BioPharma Enters into Agreement with National Cancer Center Hospital 15

Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 16

VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 18

National Cancer Center and Takeda Pharma to Develop Anti-Cancer Agents 19

Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 20

Daiichi Sankyo Enters Into Co-Development Agreement With National Cancer Center Hospital East 21

National Cancer Center Hospital-Key Competitors 22

National Cancer Center Hospital-Key Employees 23

National Cancer Center Hospital-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Strategy And Business Planning 25

Jun 01, 2018: NCC Establishes Center for Cancer Genomics and Advanced Therapeutics (C-CAT) to Aggregate and Manage Information on Cancer Genomic Medicine and Promote Its Use 25

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Key Facts 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Cancer Center Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Cancer Center Hospital, Deals By Therapy Area, 2012 to YTD 2018 8

National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

KAN Research Institute Enters into Development Agreement with Six Research Organizations 12

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 14

Oncolys BioPharma Enters into Agreement with National Cancer Center Hospital 15

Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 16

VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 18

National Cancer Center and Takeda Pharma to Develop Anti-Cancer Agents 19

Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 20

Daiichi Sankyo Enters Into Co-Development Agreement With National Cancer Center Hospital East 21

National Cancer Center Hospital, Key Competitors 22

National Cancer Center Hospital, Key Employees 23

National Cancer Center Hospital, Other Locations 24

National Cancer Center Hospital, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

National Cancer Center Hospital, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

National Cancer Center Hospital (NCC) is a healthcare service provider that offers cancer care services. The hospital provides cancer diagnosis and treatment services. It provides services such as examination, treatment, patient care services and co-medical support. NCC provides diagnosis and treatments by utilizing advanced screening and examination protocols with high-tech systems and equipment. It offers services in the areas of thoracic surgery, breast surgery, palliative care, chemotherapy, neurosurgery, ophthalmic oncology, head and neck oncology, endoscopic treatment and radiotherapy, among others. The hospital also provides consultation and examinations services by advanced computer system in the clinics. NCC is headquartered in Tokyo, Japan.

National Cancer Center Hospital-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Cancer Center Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

KAN Research Institute Enters into Development Agreement with Six Research Organizations 12

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 14

Oncolys BioPharma Enters into Agreement with National Cancer Center Hospital 15

Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 16

VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 18

National Cancer Center and Takeda Pharma to Develop Anti-Cancer Agents 19

Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 20

Daiichi Sankyo Enters Into Co-Development Agreement With National Cancer Center Hospital East 21

National Cancer Center Hospital-Key Competitors 22

National Cancer Center Hospital-Key Employees 23

National Cancer Center Hospital-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Strategy And Business Planning 25

Jun 01, 2018: NCC Establishes Center for Cancer Genomics and Advanced Therapeutics (C-CAT) to Aggregate and Manage Information on Cancer Genomic Medicine and Promote Its Use 25

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Key Facts 2

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

National Cancer Center Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

National Cancer Center Hospital, Deals By Therapy Area, 2012 to YTD 2018 8

National Cancer Center Hospital, Medical Devices Deals, 2012 to YTD 2018 9

National Cancer Center Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

KAN Research Institute Enters into Development Agreement with Six Research Organizations 12

National Cancer Center, JVCKENWOOD, Sysmex and Daiichi Sankyo Enter into Agreement 14

Oncolys BioPharma Enters into Agreement with National Cancer Center Hospital 15

Astellas Pharm, Kyowa Hakko Kirin, Daiichi Sankyo, Eisai, Ono Pharma and Chugai Pharma to Enter into Agreemet with Four Research Institutions 16

VLP Therapeutics Enters into Research Agreement with National Cancer Center Hospital 18

National Cancer Center and Takeda Pharma to Develop Anti-Cancer Agents 19

Chiome Bioscience Enters Into Co-Development Agreement With National Cancer Center Hospital 20

Daiichi Sankyo Enters Into Co-Development Agreement With National Cancer Center Hospital East 21

National Cancer Center Hospital, Key Competitors 22

National Cancer Center Hospital, Key Employees 23

National Cancer Center Hospital, Other Locations 24

National Cancer Center Hospital, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

National Cancer Center Hospital, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.